Bristol-Myers Squibb Unusual Options Activity For September 27
Portfolio Pulse from Benzinga Insights
Bristol-Myers Squibb (NYSE:BMY) has seen unusual options activity, with a large position indicating a bullish stance. The sentiment among these big-money traders is split between 70% bullish and 30% bearish. The targeted price range for Bristol-Myers Squibb over the last 3 months is from $50.0 to $65.0. The company's stock price is currently down by 1.11% at $57.89. Analysts from Cantor Fitzgerald, TD Cowen, and Truist Securities have given price targets of $75, $66, and $84 respectively.
September 27, 2023 | 8:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bristol-Myers Squibb has seen unusual options activity, indicating a bullish stance. The stock price is currently down by 1.11% at $57.89. Analysts have given price targets of $75, $66, and $84.
The unusual options activity indicates that big-money traders are taking a bullish stance on Bristol-Myers Squibb. This, combined with the price targets given by analysts, suggests that the stock price may increase in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100